Currently, researchers are exploring the use of PD-L1 to regulate T cells and modulate the biological functions of nourishing cells through binding with its receptors PD-L1 and PD-L2 for the treatment of preeclampsia [11, 12]. The gene discussed is CD274; the disease is preeclampsia.